Navigation Links
Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors
Date:1/26/2009

Stemedica Cell Technologies, Inc. announces leading stem cell specialist Dr Nabil Dib, MD as Special Advisor to its Board of Directors. Dr Dib is President of the International Society for Cardiovascular Translational Research (ISCTR) and Director of Cardiovascular and Stem Cell Consultants (CSCC).

San Diego, CA (PRWEB) January 26, 2009 -- Stemedica Cell Technologies, Inc. announces leading stem cell specialist Dr Nabil Dib, MD as Special Advisor to its Board of Directors. Dr Dib is President of the International Society for Cardiovascular Translational Research (ISCTR) and Director of Cardiovascular and Stem Cell Consultants (CSCC).

"In looking for someone to serve as Special Advisor to the Board, we sought a medical leader who had practical experience in working with the FDA and the research community in advancing therapeutic stem cell solutions. We feel fortunate to have secured an Advisory Relationship with a true leader within the stem cell industry. Dr Nabil Dib has as much extensive research, regulatory and clinical application experience with adult stem therapy as anyone in the United States," said Nikolai Tankovich, MD, PhD, President & Chief Regulatory and Medical Officer of Stemedica.

In accepting the role of Special Advisor, Dr Dib said, "I'm honored to be associated with Stemedica Cell Technologies. As someone who strives to help build this industry, my research tells me that Stemedica stands out as a leader within our sector. Many stem cell research and manufacturing companies make significant progress in the laboratory, but what distinguishes Stemedica is the extent of their clinical research experience."

"With Dr. Dib we get an independent minded, diligent investigator who has the hands on proven experience in advancing stem cell research and technology from bench top to bed side with the highest possible concern for the safety of the patient and the efficacy of the application," said Maynard Howe, PhD, Vice Chairman and CEO for Stemedica.

About Stemedica Technologies, Inc.:
Stemedica Cell Technologies Inc. is a specialty biopharmaceutical company that is committed to the development and manufacture of best-in-class adult stem cells for use by approved research institutions and hospitals for pre-clinical and clinical studies. Within the United States, the Company is currently developing regulatory pathways for traumatic brain injury and wound repair. Outside the United States, Stemedica provides its adult stem cells to hospitals and research centers that are conducting studies under protocols approved by the appropriate regulatory agencies. These studies are focused on the treatment of neurodegenerative disease, sight restoration and wound repair. Stemedica is based in San Diego, Calif.

For more information regarding Stemedica Cell Technologies or the Dr. Nabil Dib appointment, contact Dave McGuigan.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1907844.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
2. Novo Nordisk Ranks Supersector Leader in the 2007 Dow Jones Sustainability Indexes
3. AARP Disappointed in Senates Inability to Pass Health Care Reform
4. Creating Healing Environments: Healthcare Industrys Largest Sustainability Conference to be Held May 20-22 in Pittsburgh
5. Baxter Releases Ninth Annual Sustainability Report
6. Free will takes flight: how our brains respond to an approaching menace
7. New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market
8. Sun Safety Outreach to Families Takes Flight at the Plano Hot Air Balloon Festival
9. Small Army Takes on Cure for Diabetes and New Approach to Ending World Poverty with Addition of Non-Profit Accounts
10. Small Town Doctor Takes on Giants in Consumer Healthcare
11. Help is Available for Smokers Who Want to Quit as Minnesotas Smoke-Free Law Takes Effect Oct. 1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical Systems, ... and the first company to offer robotic imaging to veterinary medicine is sponsoring ... # 941 for the American Association of Equine Practitioners 62nd Annual Convention from ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... Viejo, California (PRWEB) , ... December 02, 2016 , ... ... will allow FCPX editors to create versatile lower third titles with just a few ... , Pro3rd Accents Volume 2 includes 30 lower third animations. Choose from various styles ...
(Date:12/2/2016)... ... 02, 2016 , ... On November 24th, 2016, Thanksgiving morning, ... different sites throughout Miami-Dade and Broward counties. This is the largest meal delivery ... Thanksgiving morning by putting together individual meals via assembly lines and passing them ...
(Date:12/2/2016)... ... December 02, 2016 , ... Date aired: November ... Type 2 Diabetes: The Owner’s Manual, http://realtimepressrelease.com/press-releases-tagged-with/daryl-wein , Sharon Kleyne, ... Water, Global Climate Change and Your Health radio program syndicated on Voice of ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 Orthopedic ... & Support) is Expected to Gain a Significant Market Share ... Orthopedic Ailments  ... , According to a ... on Medical Implants Sterile Packaging: Clamshell Product Type Segment Projected ...
(Date:12/2/2016)... , Dec 1, 2016 Research ... "Drug Delivery in Cancer - Technologies, Markets and Companies" ... , ... challenge in management of cancer The market value of ... Cancer market estimates from 2015-2025 are given according to organs involved ...
(Date:12/2/2016)... bioLytical Laboratories (das "Unternehmen"), ein Weltführer bei schnellen Tests für ... einer Version mit geringeren Kosten einzuführen.  Continue ... ... INSTI Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ) Der von ...
Breaking Medicine Technology: